- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Regorafenib, as a multi kinase inhibitor, commonly has side effects such as skin reactions, hypertension, fatigue, etc. Most of them can be rel...
Olaparib is a PARP inhibitor, which is suitable for the treatment of BRCA mutation related ovarian cancer, breast cancer and other malignant tu...
Olaparib, as a PARP inhibitor, commonly has side effects involving the blood system, digestive system, and fatigue. Most of these can be reliev...
The side effects of Enasidenib involve blood system, metabolic abnormalities, and gastrointestinal reactions, which need to be alleviated throu...
Enasidenib is an IDH2 inhibitor suitable for adult patients with relapsed/refractory acute myeloid leukemia (AML) carrying IDH2 mutations. It ...
Selinexor is an oral selective nuclear output inhibitor primarily used for the treatment of relapsed/refractory multiple myeloma and diffuse la...
Venetoclax is a BCL-2 inhibitor primarily used to treat hematological malignancies such as chronic lymphocytic leukemia (CLL) and acute myeloid...
The contraindications for Venetoclax involve specific drug interactions and genetic metabolic abnormalities, and medication for special populat...
Dabrafenib is a BRAFV600 mutation inhibitor mainly used to treat malignant tumors such as BRAFV600E/K mutation positive melanoma and non-small ...
The contraindications for dalafenib mesylate capsules involve specific allergic reactions and drug interactions, and medication for special pop...
